Skip to main content

Table 5 LVEF values measured before and after both antibody drug protocols

From: Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer

LVEF

Mean ± SD (%)

LVEF1 T

64.69 (SD 4.48)

LVEF2 T

60.58 (SD 6.58)

LVEF1 TE

61.75 (SD 3.85)

LVEF2 TE

59.54 (SD 4.12)